StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Merck (MRK) to Acquire Peloton Therapeutics for $1.05 Billion Upfront, Plus $1.15 Billion Contingent
May 21, 2019 6:45 AM
(Updated - May 21, 2019 6:50 AM EDT)Merck (NYSE: MRK), known as MSD outside the United States and Canada, and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Hot Corp. News
Hot M&A
Management Comments
Mergers and Acquisitions
Next Articles
Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline
May 21, 2019 6:45 AM